Investing Center Preview – Manage your investments and watch your net worth grow.
ATHA:NASDAQ – Small Cap Stock (Biotechnology)
Athira Pharma Inc – ATHA Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
0.27 | 0.00 (0.00%) | 0.253 - 3.67 | 7.8 thousand (Below Avg) |
Market data as of 4:00PM 04/01/25. Quotes are delayed by at least 15 min.
Overview - ATHA
Open | -- |
---|---|
Previous Close | 0.27 |
Day's Range | -- - -- |
Market Cap | 10.5M |
Avg Volume (10 Day) | 143.1K |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -0.963 |
Dividend Yield | No Dividend |
One-Click Scorecard - ATHA


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Pass |
Stock is undervalued? | Fail |
Have investors caught on? | Pass |
Has support of institutional investors? | Fail |
Has sufficient liquidity? | Pass |
Latest Headlines - ATHA
No news headlines available for ATHA
Industry Position - ATHA
ATHA | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 0.00% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.03 | |
LT Debt/Equity | 0.02 | |
Earnings Yield | -- | |
Price/Sales | -- |
Competitors - ATHA
Company | Last | Change |
---|---|---|
Viropro Inc | 0.00 | 0.00% |
0.37 | 0.00% | |
Ember Therapeutics Inc | 0.00 | 0.00% |
Interra Resources Corp | 0.04 | 0.00% |
10.70 | -0.93% |
Data is delayed by at least 15 min.